X T L Biopharmaceuticals reported $1.1M in Operating Expenses for its fiscal quarter ending in December of 2024.





Operating Expenses Change Date
Alaunos Therapeutics USD 952K 60K Jun/2026
Bioline Rx USD 3.87M 386K Jun/2026
Teva Pharmaceutical Industries USD 3.18B 733M Sep/2026
X T L Biopharmaceuticals USD 1.1M 175K Dec/2024